Jennifer Cullen, Ph.D.
Affiliations: | 2000 | University of California, Berkeley, Berkeley, CA, United States |
Area:
Public Health, General, EpidemiologyGoogle:
"Jennifer Cullen"Cross-listing: ID Tree
Parents
Sign in to add mentor| William A. Satariano | grad student | 2000 | UC Berkeley | |
| (Predictors of prostate cancer stage at diagnosis among Black and White members of the Northern California Kaiser Permanente Medical Care Program.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Vince RA, Sun H, Singhal U, et al. (2024) Assessing the Clinical Utility of Published Prostate Cancer Polygenic Risk Scores in a Large Biobank Data Set. European Urology Oncology |
| Wang A, Shen J, Rodriguez AA, et al. (2023) Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nature Genetics |
| Chen F, Madduri RK, Rodriguez AA, et al. (2023) Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry. European Urology |
| Basourakos SP, Gulati R, Vince RA, et al. (2022) Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men. Nejm Evidence. 1 |
| Darst BF, Hughley R, Pfennig A, et al. (2022) A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry. European Urology |
| Kiebish MA, Tekumalla P, Ravipaty S, et al. (2021) Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia. Scientific Reports. 11: 15052 |
| Marshall CH, Chen Y, Kuo C, et al. (2021) Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies. The Journal of Urology. 101097JU000000000000 |
| Zhang KW, Reimers MA, Calaway AC, et al. (2021) Cardiovascular Events in Men with Prostate Cancer Receiving Hormone Therapy: An Analysis of the FDA Adverse Event Reporting System (FAERS). The Journal of Urology. 101097JU000000000000 |
| Challa AA, Calaway AC, Cullen J, et al. (2021) Cardiovascular Toxicities of Androgen Deprivation Therapy. Current Treatment Options in Oncology. 22: 47 |
| Conti DV, Darst BF, Moss LC, et al. (2021) Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nature Genetics |